Non-Current Liabilities
Contract Liabilities, Non-Current
Thermo Fisher Scientific Contract Liabilities, Non-Current decreased by 12.6% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.3%, from $1.13B to $1.03B. Over 5 years (FY 2020 to FY 2025), Contract Liabilities, Non-Current shows an upward trend with a 9.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
Metric ID:
contract_liabilities_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $781.00M | $822.00M | $1.24B | $1.29B | $1.24B | $1.20B | $1.18B | $1.17B | $1.10B | $1.35B | $1.50B | $1.43B | $1.46B | $1.43B | $1.14B | $1.13B | $1.12B | $1.16B | $1.18B | $1.03B |
| QoQ Change | — | +5.2% | +50.6% | +4.5% | -4.4% | -3.0% | -1.8% | -0.6% | -6.3% | +22.8% | +11.2% | -4.8% | +2.0% | -1.9% | -20.3% | -1.0% | -0.4% | +3.3% | +2.1% | -12.6% |
| YoY Change | — | — | — | — | +58.4% | +46.0% | -4.8% | -9.4% | -11.2% | +12.3% | +27.1% | +21.8% | +32.5% | +5.9% | -24.1% | -21.0% | -22.9% | -18.8% | +4.0% | -8.3% |
Range$781.00M – $1.50B
CAGR+6.1%
Avg YoY Growth+5.5%
Median YoY Growth-0.4%
Contract Liabilities, Non-Current at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's contract liabilities, non-current?
- Thermo Fisher Scientific (TMO) reported contract liabilities, non-current of $1.03B in Q1 2026.
- How has Thermo Fisher Scientific's contract liabilities, non-current changed year-over-year?
- Thermo Fisher Scientific's contract liabilities, non-current decreased by 8.3% year-over-year, from $1.13B to $1.03B.
- What is the long-term trend for Thermo Fisher Scientific's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's contract liabilities, non-current has grown at a 9.2% compound annual growth rate (CAGR), from $763.00M to $1.18B.